Product Images Verzenio

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Verzenio NDC 0002-5337 by Eli Lilly And Company, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

verzenio 100mg 14ct 031 01

verzenio 100mg 14ct 031 01

This is a medication instruction for the use of Verzenio, which is a brand name for abemaciclib tablets. The medication comes in 14 tablets per pack, containing 100 mg dose each. The tablets should be swallowed whole, without chewing, crushing or splitting. Patients should take 100 mg of Verzenio twice a day, with or without food, around the same time every day. This Dose Pack contains 7 days of therapy. Missing a dose should be taken at the regular time, without taking two doses at the same time. This medicine requires a prescription (Rx only).*

verzenio 150mg 14ct 029 01

verzenio 150mg 14ct 029 01

This is a medication called Verzenio containing the active ingredient abemaciclib in 150 mg tablets that are to be taken twice a day with or without food. Each tablet contains 150 mg of abemaciclib. This pack contains 14 tablets of the 150 mg dose. The medication is only available with a prescription. Patients are advised to read the full Prescribing Information and Patient Information before taking Verzenio. The medication is to be taken at the same time every day, and any missed doses should be taken as soon as possible but not with the current dose. Patients should not change the dose or stop taking Verzenio without consulting their healthcare provider. There are instructions on the packaging on how to open the medication. Store this medication at 68 to 77°F.*

verzenio 200mg 14ct 027 01

verzenio 200mg 14ct 027 01

This is a medication instruction for Verzenio, a drug contained in a 200 mg dose pack with 14 tablets per pack. The drug is prescribed for therapeutic purposes and comes with opening instructions, precautionary measures, and dosage information. VERZENIO is to be taken orally twice a day with the morning dose of one 200 mg tablet and an evening dose of one 200 g tablet. The tablets should not be crushed or split before use, and should be swallowed whole. If a dose is missed, the patient should take the next dose as normal and under no circumstances take two doses at the same time.*

verzenio 50mg 14ct 033 01

verzenio 50mg 14ct 033 01

This is information about Verzenio tablets in a 7-day supply package, with each containing 50 mg of abemaciclib. These tablets are used as therapy and must be taken twice a day. The morning and evening dose instructions are given, with a warning not to stop taking the tablets or change the dose without consulting a medical professional. The pills should be taken whole and at the same time each day. The medication label with storage specifications is present. There are also opening instructions for the package that contains the tablets.*

Chemical Structure - verzenio pi chem struct v1

Chemical Structure - verzenio pi chem struct v1

verzenio pi f1 v3

verzenio pi f1 v3

The text describes a graph showing the progression-free survival probability percentage for patients taking VERZENIO plus NSAI and patients taking placebo plus NSAI. The x-axis represents time in months while the y-axis represents the probability of progression-free survival. The graph also shows the number of patients at risk for each treatment at different times.*

verzenio pi f2 v2

verzenio pi f2 v2

The given text represents a graph or chart that compares the number of censored observations between two groups- VERZENIO plus fulvestrant and Placebo plus fulvestrant. The data is represented in terms of the number of patients at risk over a duration of time in months. The number of patients reduces over the course of time.*

verzenio pi f3 v1

verzenio pi f3 v1

verzenio pi f4 v1

verzenio pi f4 v1

The text describes a graph that shows the invasive-disease free survival probability of cancer patients under two types of treatments( VERZENIO plus Tamoxifen or Aromatase Inhibitors and Tamoxifen or Aromatase Inhibitors). The graph covers a time period of 45 months, patients' number under observation reduces as time passes. The x-axis denotes months and the y-axis shows the percentage of the probability of survival. The text also shows the number of patients at risk at different time points.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.